bubble image

Who We Are


Arcutis Biotherapeutics (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. We are focused on filling the innovation gap in medical dermatology drug development by applying our deep clinical, product development and commercial expertise in dermatology to develop best-in-class therapies against biologically validated targets.

Our vision is to revitalize the standard of care for dermatological diseases and conditions through novel therapies that simplify disease management for physicians and eliminate the need to compromise between drug safety, efficacy and tolerability for patients. Leveraging the unparalleled experience of our leadership team, which includes the industry’s leading topical drug formulator and four dermatologists on staff, Arcutis is uniquely positioned to become the preeminent innovation-driven medical dermatology company.